HIP1R and pancreatic adenocarcinoma: To evaluate the association between HIP1R and the survival of PAAD patients, the PAAD patients were divided into HIP1R low‐expression group (n = 53) and high‐expression group (n = 53) according to median expression level of HIP1R measured by qRT‐PCR, and their clinicopathological characteristics were summarized in Table 1.